MSTN and metabolic syndrome: The over-expression of myostatin in ZF4-SC by ZFS, but also a lower but significant one by ZLS (absent in ZL4-SC), and the role of dyslipidemia in this process needs to be clarified in future studies vis-à-vis quantitative determinations of lipid factors in both types of serum.